Caesarstone (NASDAQ: CSTE) posts $397M 2025 revenue and deeper net loss amid restructuring

Rhea-AI Filing Summary

Caesarstone Ltd. reported 2025 revenue of $397.2 million, down from $443.2 million, as demand softened in key markets, especially North America. The company posted a much larger net loss of $137.5 million, versus $42.8 million in 2024, driven by restructuring and legal costs.

Closure of the Bar‑Lev manufacturing facility and related actions led to $45.7 million in non-cash impairment and $3.1 million in restructuring expenses, but are expected to contribute to total annualized savings of about $100 million since 2023. Full-year adjusted EBITDA was a loss of $32.6 million, and management reiterates an expectation for positive adjusted EBITDA in the third quarter of 2026.

Cash, cash equivalents and short-term deposits were $59.9 million with net cash of $57.5 million as of December 31, 2025, down from $101.4 million a year earlier after a $38.0 million operating cash outflow. The company also recorded a $47.2 million provision for 618 silicosis-related claims and faces ongoing tariff and legal uncertainties.

Positive

• Large cost-savings program: Strategic restructuring, including the Bar-Lev closure and move to third-party production, is expected to bring total annualized savings to about $100 million since 2023, with $20–22 million in annualized cash savings once actions are fully implemented.
• Net cash position maintained: Despite a $38.0 million operating cash outflow in 2025, Caesarstone ended the year with $59.9 million in cash and deposits and a $57.5 million net cash position, providing some balance sheet flexibility during the turnaround.

Negative

• Sharp deterioration in profitability: 2025 net loss attributable to controlling interest widened to $137.5 million from $42.8 million, with adjusted EBITDA loss growing to $32.6 million from $11.5 million, significantly weakening earnings power.
• Margin pressure and revenue decline: Revenue fell to $397.2 million from $443.2 million and gross margin dropped to 18.4% from 21.8%, as lower volumes, tariffs and competitive pressures outweighed cost actions.
• Legal and contingency overhang: The company faces 618 silicosis-related claims with a recorded provision of $47.2 million and ongoing insurance coverage litigation, creating material uncertainty for future cash flows and results.
• Rising business and tariff risk: About 47.0% of 2025 revenue came from the U.S., where existing and potential new tariffs, along with a petition seeking quotas or tariffs of up to 50% on quartz imports, could further pressure costs and demand.

Insights

Equity analyst

Revenue fell, losses widened sharply, and legal and restructuring pressures are significant.

Caesarstone saw 2025 revenue decline to $397.2M from $443.2M, while net loss expanded to $137.5M from $42.8M. Gross margin fell to 18.4%, and adjusted EBITDA loss deepened to $32.6M, reflecting weaker volumes, tariff impacts and higher operating costs.

The restructuring is substantial. Closing the Bar‑Lev facility triggered a $45.7M impairment and $3.1M in restructuring expenses, with expected annualized cash savings of $20–22M and total annualized savings of about $100M since 2023. However, operating cash flow swung from a $31.9M inflow in 2024 to a $38.0M outflow in 2025, reducing net cash to $57.5M by December 31, 2025.

Legal and regulatory risks add pressure. The company booked a $47.2M provision for 618 silicosis-related claims and is involved in insurance coverage litigation, while U.S. tariff exposure remains high with about 47.0% of 2025 revenue from the U.S. Management is targeting positive adjusted EBITDA in Q3 2026, but actual outcomes will depend on demand recovery, tariff developments and legal resolutions.

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

______________________

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

Pursuant to Rule 13a-16 or 15d-16 of the

Securities Exchange Act of 1934

For the month of March 2026

Commission File Number: 001-35464

Caesarstone Ltd.

(Translation of registrant’s name into English)

Kibbutz Sdot Yam

MP Menashe

Israel 3780400

 (Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ☒      Form 40-F ☐

EXPLANATORY NOTE

On March 4, 2026, Caesarstone Ltd. (the “Registrant”) issued a press release titled “Caesarstone Reports Fourth Quarter and Full Year 2025 Financial Results”, a copy of which is furnished as Exhibit 99.1 herewith. The financial information included in condensed consolidated balance sheets, condensed consolidated statements of income and condensed consolidated statements of cash flows contained in the press release attached as Exhibit 99.1 to this Report on Form 6-K is hereby incorporated by reference into the Registrant’s Registration Statements on Form S-8 (Files Nos. 333-180313, 333-210444 and 333-251642).  A copy of the Registrant’s updated investor presentation can be accessed at ir.caesarstone.com. The information in the investor presentation is not incorporated by reference into the Registrant’s Registration Statements.

EXHIBIT INDEX

Exhibit	Description
99.1	Press release titled “Caesarstone Reports Fourth Quarter and Full Year 2025 Financial Results” dated March 4, 2026.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	CAESARSTONE LTD.
Date: March 4, 2026	By:	/s/ Nahum Trost
		Name:  Nahum Trost
		Title:    Chief Financial Officer

Exhibit 99.1

Caesarstone Reports Fourth Quarter and Full Year 2025 Financial Results

- Fourth Quarter Revenue of $94.4 Million and Full Year Revenue of $397.2 Million -

- Implementation of Strategic Measures Expected to Bring Total Annualized Savings to Approximately

$100 Million Since 2023 -

- Reiterates Expectation to Deliver Positive Adjusted EBITDA in the Third Quarter of 2026 -

MP MENASHE, Israel – March 4, 2026 - Caesarstone Ltd. (NASDAQ: CSTE), a leading developer and manufacturer of high-quality engineered surfaces, today reported financial results for its fourth quarter and full year ended December 31, 2025.

Yos Shiran, Caesarstone’s Chief Executive Officer commented, “In 2025, we continued to reshape our business model and positioned Caesarstone for sustainable, profitable growth. We made decisive progress executing our multi-year strategic plan, most notably through the closure of our Bar-Lev manufacturing facility and the completion of our full transition of quartz production to our global network of third party production partners. This transformation represents a significant structural improvement that strengthens our competitive position and provides a foundation for long-term value creation.”

Nahum Trost, Caesarstone Chief Financial Officer added, “While we faced persistent market headwinds throughout the year, including global economic uncertainty and competitive pressures, we remained focused on the strategic initiatives that will drive long-term growth. We successfully launched our zero crystalline silica collection in Australia, ensuring regulatory compliance while maintaining market leadership. We expanded our porcelain capabilities in this growing product category and we continued to invest in brand strength, product innovation, and customer service excellence. With the Bar-Lev closure behind us and our transition to third party production partners  progressing as planned, we enter 2026 with a significantly more flexible and efficient operating structure. This step change in our transformation, combined with other recent cost mitigation efforts, is expected to deliver over $25 million in annual cost savings, which brings our total annualized savings to approximately $100 million since 2023.”

Manufacturing Facility Network and Cost Optimization Update

As previously announced, on November 11, 2025, the Company approved additional steps under its strategic restructuring plan across the Company’s operations, commencing with the closure of its manufacturing facility in Bar-Lev, Israel, and a reduction in headcount of approximately 200 employees mostly associated with that facility. Production at the Bar-Lev facility ceased in December 2025. Existing inventory from prior Bar-Lev production will continue to be sold down into 2026, primarily during the first half of the year. This part of the restructuring plan is intended to increase competitiveness, help improve the Company’s profitability and cash flows, improve service and drive additional cost efficiencies through an optimized manufacturing footprint.

In connection with the facility closure, the Company incurred non-cash impairment expenses of $45.7 million and restructuring expenses of $3.1 million primarily related to the facility closure. These impairment expenses include a non-cash write-down on the long-term non-cancellable facility lease agreement, valid through 2032, which the Company aims to sublease in whole or in part through the remaining term of the lease.

The Company incurred cash costs of $0.8 million during the fourth quarter and expects to incur additional cash costs in the amount of $3.0 million to $5.0 million related to operations through the next 12 months.

Once fully implemented the Company expects to realize annualized cash savings of approximately $20.0 to $22.0 million, with the potential for additional cash savings if subleases are executed on the non-cancellable long-term facility lease agreement. Upon closure of the Bar-Lev facility, the Company will continue to maintain its high level of service to customers through its third party production partners.

The Company also continues to make progress in its efforts to monetize its previously closed Richmond Hill, GA facility.

Beyond the facility closures, the Company’s restructuring plan continues to focus on additional actions that can be taken to improve future profitability and cash flow and help the Company to invest in its brand, innovation and porcelain. In addition, the Company believes these actions will help to achieve its goal to return to profitability during the third quarter of 2026.

Fourth Quarter 2025 Results

Revenue in the fourth quarter of 2025 was $94.4 million compared to $97.9 million in the prior year quarter. On a constant currency basis, fourth quarter revenue was off by 5.0% year-over-year, reflecting continued softness in global demand and competitive pressures, particularly in North America, partially offset by strength in Australia following the launch of the Company’s full collection of zero crystalline silica products and a more favorable operating environment in Israel.

Gross margin in the fourth quarter of 2025 was 15.5% compared to 19.4% in the prior year quarter. Excluding one-time expenses mainly related to the closure of the Bar-Lev facility, adjusted gross margin for the quarter was 18.0% compared to 19.7% in the prior year quarter. The difference in adjusted gross margin was primarily due to lower fixed cost absorption resulting from reduced production and sales volumes and the impact of recent tariffs which were not covered in full by the Company’s pricing actions implemented in the beginning of the quarter, partially offset by benefits from an improved production footprint.

Operating expenses in the fourth quarter of 2025 were $96.9 million, or 102.6% of revenue, compared to $41.9 million, or 42.9% of revenue in the prior year quarter. Excluding legal settlements and loss contingencies, restructuring and impairment expenses, operating expenses were $32.0 million or 33.9% of revenue compared to $32.6 million or 33.3% in the prior year quarter.

Operating loss in the fourth quarter of 2025 was $82.3 million compared to an operating loss of $23.0 million in the prior year quarter. The increased operating loss primarily reflects non-cash impairment expenses of $45.7 million mainly related to the Bar-Lev facility closure, along with $3.1 million in restructuring expenses.

Adjusted EBITDA in the fourth quarter of 2025, which excludes expenses for non-cash share-based compensation, legal settlements and loss contingencies, restructuring charges, impairment expenses and other non-recurring items, was a loss of $11.1 million compared to a loss of $8.0 million in the prior year quarter.

Finance expenses in the fourth quarter of 2025 were $2.7 million compared to finance expenses of $2.9 million in the prior year quarter. Finance expenses result mainly from foreign currency exchange rate fluctuations.

Net loss attributable to controlling interest for the fourth quarter of 2025 was $87.9 million compared to a net loss of $24.3 million in the prior year quarter. Net loss per share for the fourth quarter 2025 was $2.55 compared to a net loss per share of $0.60 in the prior year quarter. Adjusted diluted net loss per share for the fourth quarter was $0.48 on 34.6 million shares, compared to adjusted diluted net loss per share of $0.35 in the prior year quarter on 34.7 million shares.

Full Year 2025 Results

Revenue in 2025 was $397.2 million compared to $443.2 million in 2024. On a constant currency basis, full year revenue was off by 10.5% year-over-year, primarily due to lower volumes resulting from global economic headwinds and competitive pressures across the Company's main regions.

Gross margin in 2025 was 18.4% compared to 21.8% in 2024. Excluding one time expenses mainly related to the closure of the Bar-Lev plant, adjusted gross margin for the year was 19.0% compared to 22.1% in the prior year. The difference in gross margin was primarily due to lower volumes and production, which resulted in lower fixed cost absorption, partially offset by benefits from an improved production footprint.

Operating expenses in 2025 were $199.0 million, or 50.1% of revenue, compared to $138.6 million, or 31.3% of revenue in 2024. Excluding legal settlements and loss contingencies, restructuring and impairment expenses, operating expenses were $124.7 million or 31.4% of revenue compared to $130.3 million or 29.4% in 2024. The improvement in absolute dollars reflects the benefits of cost reduction initiatives.

Operating loss in 2025 was $125.7 million compared to an operating loss of $41.9 million in 2024. The increased loss primarily reflects non-cash impairment expenses of $45.7 million related to the Bar-Lev facility closure.

Adjusted EBITDA in 2025, which excludes non-cash impairment and restructuring charges, expenses for share-based compensation, legal settlements and loss contingencies and restructuring and impairment expenses and non-recurring items, was a loss of $32.6 million compared to a loss of $11.5 million in 2024.

Finance expenses in 2025 were $7.8 million compared to breakeven in 2024. The difference primarily reflects foreign currency exchange rate fluctuations.

Net loss attributable to controlling interest in 2025 was $137.5 million compared to a net loss of $42.8 million in 2024. Net loss per share for the full year 2025 was $3.98 compared to a net loss per share of $1.13 in 2024. Adjusted diluted net loss per share for the full year was $1.50 on 34.7 million shares, compared to adjusted diluted net loss per share of $0.86 in 2024 on 34.7 million shares.

Balance Sheet & Liquidity

As of December 31, 2025, the Company's balance sheet included cash, cash equivalents and short-term bank deposits of $59.9 million and total debt to financial institutions of $2.4 million. The Company's net cash position was $57.5 million as of December 31, 2025, compared to a net cash position of $101.4 million as of December 31, 2024.

U.S. Tariffs Update

The Company continues to monitor the impact of existing and proposed U.S. tariffs affecting various countries and product categories, that are currently in a wide range on the majority of imported products. Approximately 47.0% of the Company's revenues during the twelve-month period ended December 31, 2025 were generated in the U.S. market, served by the Company's global production network. The Company is in continuous dialogue with its manufacturing partners to optimize its supply chain and has taken the appropriate pricing actions in the U.S. market to mitigate the increased cost of goods imported to the U.S.

In addition to these tariffs, on September 15, 2025, a petition was filed with the U.S. International Trade Commission by a U.S. quartz manufacturer alleging serious financial damages caused to the entire U.S. domestic industry by imports of quartz surface products, seeking hard quotas on the quantity of quartz surface products that can be imported into the U.S. and/or tariffs of up to 50% on all quartz surface products that are imported into the U.S. from any foreign country. In response to this petition, a multitude of objections were submitted by U.S. domestic businesses, including fabricators. This process is expected to be completed during 2026.

Legal Proceedings Update

As of December 31, 2025, the Company was subject to lawsuits involving 618 individuals alleging injuries related to exposure to respirable crystalline silica dust. These included 40 claims in Israel, 151 in Australia, and 427 in the United States. As of the same date, the Company recorded a provision of $47.2 million, representing its best estimate of probable and reasonably estimable losses associated with pending claims. The Company’s insurance receivables related to these silicosis claims totaled $11.0 million.

In the U.S. during 2025, a jury in California ruled in favor of the Company, assigning no liability to the Company in one trial. This case remains under appeal. The Company settled another claim during 2025 and four additional claims in February 2026. The Company also received one adverse jury verdict in 2024, which is currently under appeal. The remaining U.S. claims are either at an early stage or are considered only reasonably possible losses, and therefore no additional provision has been recorded.

In July 2025, both the Company and certain U.S. insurance carriers initiated proceedings for declaratory relief to determine the proper interpretation and application of the Company’s U.S. product liability insurance policies and available limits. These proceedings are in an early stage.

If there is a change in the assessment for the outcome of the claims or the insurance coverage limits through the course of the trial processes, such changes could have a material and adverse impact on our business, financial position, results of operations and cash flows. Additional information related to legal proceedings can be found in the Company’s Annual Report on form 20-F for the year ended December 31, 2025.

Closing Comment

"We enter 2026 with a significantly more flexible and efficient operational structure. We expect our  improvements to support our return to positive adjusted EBITDA in the third quarter of 2026, positioning Caesarstone to better capitalize on a market recovery and deliver consistent value for our shareholders,” concluded Mr. Trost.

About Caesarstone

Caesarstone is a global leader of premium surfaces, specializing in countertops that create dynamic spaces of inspiration in the heart of the home. Established in 1987, its multi-material portfolio of over 100 colors combines the company’s innovative technology with its powerful design passion. Spearheading high-quality, sustainable surfaces, Caesarstone delivers functional resilience with timeless beauty, for a vast range of applications, including kitchen countertops, bathroom vanities, and more, for indoor and outdoor spaces.

Since it pioneered quartz countertops over thirty years ago, the brand has expanded into porcelain and natural stone and is on the ground in more than 50 countries worldwide while enhancing customer experience through the expansion of groundbreaking digital platforms & services. More information on Caesarstone: caesarstoneus.com, Facebook, LinkedIn  and Instagram

The Company has filed its annual report on Form 20-F for the year ended December 31, 2025 with the U.S. securities and exchange commission (“SEC”) and can be accessed on its website.

Non-GAAP Financial Measures

The non-GAAP measures presented by the Company should be considered in addition to, and not as a substitute for, comparable GAAP measures. Reconciliations of GAAP gross profit to Adjusted gross profit, GAAP net income (loss) to Adjusted net income (loss) and net income (loss) to Adjusted EBITDA are provided in the schedules to this release. To calculate revenues growth rates that exclude the impact of changes in foreign currency exchange rates, the Company converts actual reported results from local currency to U.S. dollars using constant foreign currency exchange rates in the current and comparable period. The Company provides these non-GAAP financial measures because it believes that they present a better measure of the Company's core business and management uses the non-GAAP measures internally to evaluate the Company's ongoing performance. Accordingly, the Company believes that they are useful to investors in enhancing an understanding of the Company's operating performance.

Forward-Looking Statements

Information provided in this press release may contain statements relating to current expectations, estimates, forecasts and projections about future events that are "forward-looking statements" within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as “goals," “intend,” “seek,” “anticipate,” “believe,” “could,” “continue,” “expect,” “estimate,” “may,” “plan,” “outlook,” “future” and “project” and other similar expressions that predict, project or indicate future events or trends or that are not statements of historical matters. Such forward-looking statements include statements regarding the Company’s goals and plans, intentions, expectations, assumptions, goals and beliefs regarding the Company’s business. Actual results may differ materially from those projections and estimates due to various risks and uncertainties, both known or unknown. These factors include, but are not limited to: the effects of the global and regional economy and geo-politics on the Company’s business and operations including the length, duration and impact of the war in Israel, the Houthi’s disruption to the movement of goods in the Red Sea and trade disruptions such as Turkey’s decision not to trade with Israel; the outcome of silicosis and other bodily injury claims, and the availability of relevant insurance; regulatory changes and requirements relating to the manufacturing and fabrication of our products; the outcome of our restructuring efforts, of the closure of the Sdot Yam and Richmond Hill Facilities, the estimated closure costs and the estimated potential savings relating to said closures, the ability to sell or sublease all or part of these facilities; our ability to effectively collaborate with production business partners; our R&D and product introduction efforts, managing constraints in the global supply chain and effectively procuring raw materials and goods as well as fluctuations in their price; our ability to mitigate the recently imposed U.S. customs tariffs; our ability to protect our brand, technology and intellectual property, as well as our freedom to operate; competitive pressures; disruptions to our information technology systems, fluctuations in currency exchange rates against the U.S. dollar; our ability to successfully integrate our acquisitions; our ability to meet ESG goals and targets; and other risks and uncertainties discussed under the sections "Risk Factors" and “Special Note Regarding Forward-Looking Statements and Risk Factor Summary” in our most recent annual report on Form 20-F filed with the Securities and Exchange Commission (the “SEC”) on March 4, 2026, and in other documents filed by Caesarstone with the SEC, which are available free of charge at www.sec.gov. These forward-looking statements are made only as of the date hereof, and the Company undertakes no obligation to update or revise the forward-looking statements, whether as a result of new information, future events or otherwise.

Investor Relations:

ICR, Inc. - Rodny Nacier

CSTE@icrinc.com

+1 (646) 200-8870

Caesarstone Ltd. and its subsidiaries

 Condensed consolidated balance sheets

		As of
U.S. dollars in thousands		December 31, 2025				December 31, 2024
		(Audited)				(Audited)
ASSETS
CURRENT ASSETS:
Cash and cash equivalents and short-term bank deposits		$	59,920			$	106,336
Trade receivables, net			48,292				46,880
Other accounts receivable and prepaid expenses			50,601				82,651
Inventories			94,275				112,609
Total current assets			253,088				348,476
LONG-TERM ASSETS:
Severance pay fund			1,245				1,526
Deferred tax assets, net			4,010				2,910
Long-term deposits and prepaid expenses			5,179				4,750
Operating lease right-of-use assets			104,774				115,392
Property, plant and equipment, net (*)			30,146				75,724
Intangible assets, net			-				263
Total long-term assets			145,354				200,565
Total assets		$	398,442			$	549,041
LIABILITIES AND EQUITY
CURRENT LIABILITIES:
Short-term bank credit and other loans		$	2,853			$	4,555
Trade payables			37,779				52,838
Related parties			247				206
Short term legal settlements and loss contingencies			38,577				42,706
Accrued expenses and other liabilities			58,718				51,383
Total current liabilities			138,174				151,688
LONG-TERM LIABILITIES:
Long-term bank and other loans			-				444
Legal settlements and loss contingencies long-term and other liabilities			8,735				9,492
Deferred tax liabilities, net			2,168				2,439
Long-term lease liabilities			106,377				107,313
Accrued severance pay			2,886				2,978
Long-term warranty provision			889				902
Total long-term liabilities			121,055				123,568
REDEEMABLE NON-CONTROLLING INTEREST			-				2,200
EQUITY:
Ordinary shares			371				371
Treasury shares - at cost			(39,430	)			(39,430	)
Additional paid-in capital			167,700				166,500
Capital fund related to non-controlling interest			(5,587	)			(5,587	)
Accumulated other comprehensive income (loss), net			(10,874	)			(14,870	)
Retained earnings			27,033				164,601
Total equity			139,213				271,585
Total liabilities and equity		$	398,442			$	549,041

Caesarstone Ltd. and its subsidiaries

  Condensed consolidated statements of income (loss)

		Three months ended December 31,								Twelve months December 31,
U.S. dollars in thousands (except per share data)		2025				2024				2025				2024
		(Unaudited)								(Audited)
Revenues		$	94,435			$	97,863			$	397,228			$	443,221
Cost of revenues			79,827				78,875				323,948				346,546
Gross profit			14,608				18,988				73,280				96,675
Operating expenses:
Research and development			1,361				1,446				5,674				4,950
Sales and Marketing			20,290				20,191				79,521				86,239
General and administrative			10,381				10,915				39,486				39,123
Restructuring expenses (*)			3,050				7,763				3,096				1,007
Impairment expenses (**)			45,657				-				45,657				-
Legal settlements and loss contingencies, net			16,177				1,629				25,555				7,242
Total operating expenses			96,916				41,944				198,989				138,561
Operating loss			(82,308	)			(22,956	)			(125,709	)			(41,886	)
Finance expenses, net			2,747				2,860				7,766				9
Loss before taxes			(85,055	)			(25,816	)			(133,475	)			(41,895	)
Tax expenses (income), net			2,881				(1,361	)			4,284				1,081
Net loss		$	(87,936	)		$	(24,455	)		$	(137,759	)		$	(42,976	)
Net loss attributable to non-controlling interest			-				111				292				144
Net loss attributable to controlling interest		$	(87,936	)		$	(24,344	)		$	(137,467	)		$	(42,832	)
Basic net loss per ordinary share (***)		$	(2.55	)		$	(0.60	)		$	(3.98	)		$	(1.13	)
Diluted net loss per ordinary share (***)		$	(2.55	)		$	(0.60	)		$	(3.98	)		$	(1.13	)
Weighted average number of ordinary shares used in computing basic loss per ordinary share			34,572,774				34,547,633				34,569,215				34,539,378
Weighted average number of ordinary shares used in computing diluted loss per ordinary share			34,572,774				34,547,633				34,569,215				34,539,378

(*) Related to closed plants.

(**) Impairment related to long lived assets.

(***) The numerator for the calculation of net loss per share for the three and twelve months ended December 31, 2025 and 2024, has been (increased)/decreased by approximately ($0.1) and $3.8 million, respectively, to reflect the adjustment to redemption value associated with the redeemable non-controlling interest.

Caesarstone Ltd. and its subsidiaries

Selected Condensed consolidated statements of cash flows

		Twelve months ended December 31,
U.S. dollars in thousands		2025				2024
		(Audited)
Cash flows from operating activities:
Net loss		$	(137,759	)		$	(42,976	)
Adjustments required to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization			14,199				17,134
Share-based compensation expense			1,200				2,044
Accrued severance pay, net			189				392
Changes in deferred tax, net			(961	)			(621	)
Capital loss			149				980
Legal settlemnets and loss contingencies, net			25,555				18,748
Decrease in trade receivables			88				6,857
Decrease in other accounts receivable and prepaid expenses			10,966				20,128
Decrease in inventories			21,099				8,952
Decrease in trade payables			(15,342	)			(579	)
Increase in warranty provision			170				7,242
Changes in right of use assets			14,213				3,371
Changes in lease liabilities			(1,959	)			(5,006	)
Contingent consideration related to acquisitions			-				(53	)
Decrease in accrued expenses and other liabilities including related parties			(18,589	)			(5,746	)
Restructuring expenses and Impairment related to long lived assets			48,753				1,007
Net cash (used in) provided by operating activities			(38,029	)			31,874
Cash flows from investing activities:
Net cash paid for acquisitions			-				(1,556	)
Purchase of property, plant and equipment			(9,036	)			(10,421	)
Proceeds from sale of property, plant and equipment			3,735				67
Decrease (increase) in long term deposits			(243	)			51
Net cash used in investing activities			(5,544	)			(11,859	)
Cash flows from financing activities:
Changes in short-term bank credits and long-term loans, including related parties			(1,960	)			(2,545	)
Payments related to transactions with non-controlling interest			(1,920	)			-
Contingent consideration related to acquisition			-				(500	)
Net cash used in financing activities			(3,880	)			(3,045	)
Effect of exchange rate differences on cash and cash equivalents			1,037				(1,757	)
Increase (decrease) in cash and cash equivalents and short-term bank deposits			(46,416	)			15,213
Cash and cash equivalents and short-term bank deposits at beginning of the period			106,336				91,123
Cash and cash equivalents and short-term bank deposits at end of the period		$	59,920			$	106,336
Non - cash investing:
Changes in trade payables balances related to purchase of fixed assets			(103	)			106

Caesarstone Ltd. and its subsidiaries

		Three months ended December 31,								Twelve months December 31,
U.S. dollars in thousands		2025				2024				2025				2024
		(Unaudited)								(Unaudited)
Reconciliation of Gross profit to Adjusted Gross profit:
Gross profit		$	14,608			$	18,988			$	73,280			$	96,675
Share-based compensation expense (a)			14				11				51				89
Amortization of assets related to acquisitions			66				70				270				282
Residual operating expenses (income) related to closed plants after closing			(31	)			96				180				672
Other non recuring items (b)			2,311				141				1,855				182
Adjusted Gross profit (Non-GAAP)		$	16,968			$	19,306			$	75,636			$	97,900

(a)	Share-based compensation includes expenses related to stock options and restricted stock units granted to employees and directors of the Company.
(b)	Non recurring items related mainly to restructuring.

Caesarstone Ltd. and its subsidiaries

		Three months ended December 31,								Twelve months December 31,
U.S. dollars in thousands		2025				2024				2025				2024
		(Unaudited)								(Unaudited)
Reconciliation of Net Loss to Adjusted EBITDA:
Net loss		$	(87,936	)		$	(24,455	)		$	(137,759	)		$	(42,976	)
Finance expenses, net			2,747				2,860				7,766				9
Taxes on income, net			2,881				(1,361	)			4,284				1,081
Depreciation and amortization			3,921				4,363				14,807				17,742
Legal settlements and loss contingencies, net (a)			16,177				1,629				25,555				7,242
Contingent consideration adjustment related to acquisition			-								-				(53	)
Share-based compensation expense (b)			241				434				1,200				2,044
Restructuring expense  (c)			3,050				7,827				3,096				1,005
Impairment expenses (d)			45,657				-				45,657				-
Residual operating expenses related to closed plants after closing			(193	)			450				979				2,056
Other non recuring items (e)			2,311				284				1,855				325
Adjusted EBITDA (Non-GAAP)		$	(11,144	)		$	(7,969	)		$	(32,560	)		$	(11,525	)

(a)	Consists primarily of legal settlements expenses and loss contingencies, net, related to product liability claims.
(b)	Share-based compensation includes expenses related to stock options and restricted stock units granted to employees and directors of the Company.
(c)	Related to closed plants activities.
(d)	Impairment related to long lived assets.
(e)	Non recurring items related mainly to restructuring.

Caesarstone Ltd. and its subsidiaries

		Three months ended December 31,								Twelve months December 31,
U.S. dollars in thousands (except per share data)		2025				2024				2025				2024
		(Unaudited)								(Unaudited)
Reconciliation of net loss attributable to controlling interest to adjusted net loss attributable to controlling interest:
Net loss attributable to controlling interest		$	(87,936	)		$	(24,344	)		$	(137,467	)		$	(42,832	)
Legal settlements and loss contingencies, net (a)			16,177				1,629				25,555				7,242
Contingent consideration adjustment related to acquisition			-								-				(53	)
Amortization of assets related to acquisitions, net of tax			47				532				376				2,135
Share-based compensation expense (b)			241				434				1,200				2,044
Acquisition and integration related expenses			-				-				-				-
Non cash revaluation of lease liabilities (c)			1,745				977				4,163				(2,039	)
Restructuring expenses (d)			3,050				7,826				3,096				1,005
Impairmet expenses (e)			45,657				-				45,657				-
Residual operating expenses related to closed plants after closing			(193	)			450				979				2,056
Other non recuring items (f)			2,311				284				1,855				325
Total adjustments			69,035				12,132				82,881				12,715
Less tax on non-tax adjustments (g)			(2,259	)			(240	)			(2,660	)			(328	)
Total adjustments after tax			71,294				12,372				85,542				13,043
Adjusted net loss attributable to controlling interest (Non-GAAP)		$	(16,642	)		$	(11,972	)		$	(51,925	)		$	(29,789	)
Adjusted loss per share (h)		$	(0.48	)		$	(0.35	)		$	(1.50	)		$	(0.86	)

(a)	Consists primarily of legal settlements expenses and loss contingencies, net, related to product liability claims.
(b)	Share-based compensation includes expenses related to stock options and restricted stock units granted to employees and directors of the Company.
(c)	Exchange rate diffrences deriving from revaluation of lease contracts in accordance with FASB ASC 842.
(d)	Related to closed plants activities.
(e)	Related to closed plants activities.
(f)	Non recurring items related mainly to restructuring.
(g)	Tax adjustments for the three and twelve months ended December 31, 2025 and 2024, based on the effective tax rates.
(h)	In calculating adjusted (Non-GAAP) loss per share, the diluted weighted average number of shares outstanding excludes the effects of share-based compensation expense in accordance with FASB ASC 718.

Caesarstone Ltd. and its subsidiaries

Geographic breakdown of revenues by region

		Three months ended December 31,								Twelve months December 31,								Three months ended December 31,								Twelve months December 31,
U.S. dollars in thousands		2025				2024				2025				2024
		(Unaudited)								(Unaudited)				(Audited)				YoY % change				YoY % change CCB				YoY % change				YoY % change CCB
USA		$	41,420			$	46,353			$	186,885			$	219,559				(10.6	)%			(10.6	)%			(14.9	)%			(14.9	)%
Canada			10,966				14,106				51,874				61,749				(22.3	)%			(22.3	)%			(16.0	)%			(14.1	)%
Latin America			656				244				1,461				1,392				168.9	%			171.5	%			5.0	%			5.1	%
America's			53,042				60,703				240,220				282,700				(12.6	)%			(12.6	)%			(15.0	)%			(14.6	)%
Australia			18,515				16,870				67,480				75,388				9.8	%			9.8	%			(10.5	)%			(8.5	)%
Asia			5,347				4,317				18,224				20,577				23.9	%			25.1	%			(11.4	)%			(10.4	)%
APAC			23,862				21,187				85,704				95,965				12.6	%			12.9	%			(10.7	)%			(8.9	)%
EMEA			12,105				11,858				51,952				47,121				2.1	%			(5.3	)%			10.3	%			6.2	%
Israel			5,426				4,115				19,352				17,435				31.9	%			17.2	%			11.0	%			3.3	%
Total Revenues		$	94,435			$	97,863			$	397,228			$	443,221				(3.5	)%			(5.0	)%			(10.4	)%			(10.5	)%

FAQ

How did Caesarstone (CSTE) perform financially in full-year 2025?

Caesarstone’s 2025 revenue was $397.2 million, down from $443.2 million in 2024, reflecting softer demand and competitive pressures. Net loss attributable to controlling interest increased to $137.5 million, driven by restructuring, impairment, legal contingencies and weaker margins across its operations.

What were Caesarstone (CSTE)’s key fourth quarter 2025 results?

In Q4 2025, Caesarstone generated $94.4 million in revenue versus $97.9 million a year earlier. It reported a net loss attributable to controlling interest of $87.9 million, including a $45.7 million non-cash impairment tied mainly to the Bar-Lev facility closure and restructuring-related expenses.

What restructuring steps is Caesarstone (CSTE) taking and what savings are expected?

Caesarstone closed its Bar-Lev manufacturing facility, reduced headcount by about 200 employees, and shifted quartz production to third-party partners. These actions, alongside other initiatives, are expected to deliver annualized cash savings of $20–22 million and bring total annualized savings since 2023 to about $100 million.

What is Caesarstone (CSTE)’s cash and debt position at year-end 2025?

As of December 31, 2025, Caesarstone held $59.9 million in cash, cash equivalents and short-term deposits, with total debt to financial institutions of $2.4 million. This resulted in a net cash position of $57.5 million, down from $101.4 million a year earlier.

How significant are silicosis-related legal claims for Caesarstone (CSTE)?

As of December 31, 2025, Caesarstone faced 618 silicosis-related claims across Israel, Australia and the U.S. It recorded a $47.2 million provision for probable losses and reported $11.0 million of related insurance receivables, while some claims and insurance coverage issues remain under litigation or appeal.

What guidance has Caesarstone (CSTE) provided on future profitability?

Management reiterated an expectation to achieve positive adjusted EBITDA in the third quarter of 2026, supported by its restructuring program, cost savings and shift to third-party production. This goal depends on execution of strategic measures and broader demand, tariff and legal developments in its key markets.

How exposed is Caesarstone (CSTE) to U.S. tariffs and trade actions?

About 47.0% of Caesarstone’s 2025 revenue came from the U.S., where existing customs tariffs and a petition seeking hard quotas or tariffs up to 50% on quartz imports pose risk. The company is coordinating with manufacturing partners and adjusting pricing to mitigate increased import costs.

Filing Exhibits & Attachments

1 document

Press Releases

• EX-99.1 EXHIBIT 99.1 537.6 KB